Showing results (771-780 of 1,007) with videos related to

Sort By:
Pageof 101
Neurology. Genetics|August 2, 2018
Longitudinal analysis of contrast acuity in Friedreich ataxiaAli G Hamedani, Lauren A Hauser, Susan Perlman, et al.
Environmental Pollution (Barking, Essex : 1987)|September 6, 2016
Mercury, selenium and stable isotopes in four small cetaceans from the Southeastern Brazilian coast: Influence of feeding strategyGilberto Baptista, Helena A Kehrig, Ana Paula M Di Beneditto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2023
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's DiseaseC Warren Olanow, Robert A Hauser, Daniel J Burdick, et al.
Parkinsonism & Related Disorders|March 15, 2001
The long-term safety and efficacy of pramipexole in advanced Parkinson's diseaseW J. Weiner, S A. Factor, J Jankovic, et al.
Human Genetics|April 14, 2005
Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson diseaseMaher A Noureddine, Xue-Jun Qin, Sofia A Oliveira, et al.
Molecular Vision|December 20, 2008
Optineurin coding variants in Ghanaian patients with primary open-angle glaucomaYutao Liu, Stephen Akafo, Cecile Santiago-Turla, et al.
Parkinsonism & Related Disorders|April 5, 2025
A validation study of the Clinician's Tardive Inventory (CTI)Richard M Trosch, Alicia C Shillington, Cynthia L Comella, et al.
Journal of Biomedical Science|January 15, 2010
ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseasesPaul Gutwein, Anja Schramme, Mohamed Sadek Abdel-Bakky, et al.
The Lancet. Neurology|December 11, 2019
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 studyC Warren Olanow, Stewart A Factor, Alberto J Espay, et al.
Pageof 101